Humana to report first-quarter earnings amid Medicare Advantage cost pressures

9 articles · Updated · Barron's · Apr 28

Wall Street expects Humana’s adjusted EPS to fall to $10.20, with revenue rising to $39.37 billion and medical cost ratio increasing to 89.7%.
Humana’s growing Medicare Advantage membership heightens scrutiny as higher federal payment rates and rising healthcare utilization impact profitability and market performance.
The company’s stock has fluctuated this year due to changes in federal payment rate proposals, with analysts divided on whether membership growth will help or hurt future results.

How will Humana manage rising GLP-1 drug costs without drastically raising premiums or cutting essential benefits for its members?

Humana added 1.2 million members while rivals fled. Is this a brilliant market capture or a high-stakes gamble that could backfire?

With insurers trimming benefits, what specific perks are most at risk for Medicare Advantage members in 2027?

As insurers merge with providers, how can regulators stop companies from hiding profits and bypassing patient protection rules?

Beyond just increasing bills, can AI actually be used to lower healthcare costs and improve outcomes for seniors?

A new bill targets prior authorization abuse. Will this legislation have real teeth, or is it merely symbolic for patients?